MSSPT PEPTIDE PEN LOVERS PEN – R 1000

Bremelanotide (PT–141) is a synthetic cyclic heptapeptide analog of a–melanocyte-stimulating hormone (a-MSH). It is a potent agonist of melanocortin receptors, particularly MC3R and MC4R. 

Mechanism of Action 

PT-141 selectively activates melanocortin receptors in the central nervous system (hypothalamus and limbic system). This triggers: 

• Increased sexual arousal and desire via neural pathways independent of vascular mechanisms 
• Modulation of dopamine and other neurotransmitters involved in sexual motivation 
• Mild melanotropic effects (skin pigmentation) at higher cumulative doses 

Unlike PDE5 inhibitors (e.g., sildenafil), PT-141 acts centrally on the brain to enhance libido and sexual response in both men and women. 

Indications & Usage 

Lovers Pen (Bremelanotide / PT-141) is used to support sexual desire and arousal. It is indicated for: 

• Enhancement of sexual motivation, arousal, and satisfaction 
• Support for hypoactive sexual desire or reduced libido 
• Assistance in improving intimate experiences and sexual wellness 

Contraindications & Warnings 

Do not use if you have: 

• Known hypersensitivity to Bremelanotide or any excipient 
• Uncontrolled hypertension or severe cardiovascular disease 
• History of melanoma or skin cancer 
• Pregnancy or breastfeeding 
• Age under 18 years 

Warnings 

• Use only under medical supervision. 
• Not a substitute for addressing underlying relationship, psychological, or medical causes of sexual dysfunction. 
• May cause temporary increase in skin pigmentation or darkening of moles. 
• Discontinue immediately and seek medical attention if severe symptoms occur (e.g., severe nausea, high blood pressure, or allergic reaction). 

Dosage & Administration 

• Subcutaneous injection only. 
• Standard / Effective Dose: 1.0-1.75 mg (24-42 clicks) 
• Starting / Low Dose: 0.5-1.0 mg (12-24 clicks) – recommended for first-time use 
• Frequency: As-needed, at least 45 minutes (ideally 45-60 minutes) before activity 
• Maximum: Do not exceed 1 dose per 24 hours or 8 doses per month 
• Timing: Inject 45-60 minutes prior to anticipated activity 

Administration Instructions 

1. Attach a sterile needle. 
2. Dial your dose (e.g., 24 clicks = 1.0 mg). 
3. Clean injection site (abdomen or thigh) with alcohol swab. 
4. Insert needle at 45-90° angle and inject slowly. 
5. Withdraw needle, dispose safely, and cap the pen. 
6. Rotate injection sites. 
7. Always inspect solution: Do not inject if cloudy, discoloured, or containing particles. 

Side Effects 

Common or potential reactions include: 

• Mild to moderate nausea (most common, usually temporary) 
• Flushing, headache, or light-headedness 
• Injection-site irritation or redness 
• Temporary increase in skin pigmentation or darkening of freckles/moles 
• Rare: Increased blood pressure, vomiting, or fatigue 
• If severe nausea, vomiting, or cardiovascular symptoms occur, discontinue use and seek medical attention. 

Storage & Handling 

• Store either in refrigerator (fridge); never freeze or in a cool dry place (≤25-30°C / 77-86°F). Keep pen capped and protected from light and heat. 
• After first use: Same storage conditions. 
• Keep out of reach of children. 
• Discard if expired or solution appears abnormal.

Powered by Precision MSSPT 

Peptide Pen formulations set the standard for research peptide delivery in challenging environments. Powered by exclusive MSSPT, each pen combines buffers, antioxidants, and proprietary agents in a compact, user-friendly injector delivering strict control over pH, light, oxygen, oxidative factors, and moisture even under South Africa’s subtropical variability or the UAE’s extreme desert heat and humidity. This proprietary technology positions Peptide Pen as the premier choice for researchers in these regions: no mixing, no guesswork, and reliable, high-fidelity results despite demanding protocols and climates. Every Peptide Pen is built for exceptional durability, reliability, and performance providing precision molecular stabilization in every dose, wherever your research takes you. 

IMPORTANT NOTICE 

This product is not intended to diagnose, treat, cure, or prevent any disease. Statements have not been evaluated by the FDA, SAHPRA, or other authorities. Always consult a licensed healthcare provider before use, especially if pregnant, breastfeeding, under 18, or managing medical conditions.

MSSPT PEPTIDE PEN LIMITLESS – R1600

Limitless combines three synergistic compounds that target cellular energy, mitochondrial function, and metabolic regulation: 

• NAD* (Nicotinamide Adenine Dinucleotide): A critical coenzyme present in all living cells. It exists in oxidized (NAD*) and reduced (NADH) forms. 
• MOTS-C: A 16-amino-acid mitochondrial-derived peptide (MDP). Sequence: MRWQEMGYIFYPRKLR. 
• 5-Amino-1MQ: A small-molecule quinolinium derivative (5-amino-1-methylquinolinium).

Mechanism of Action 

• NAD* serves as a substrate for sirtuins (SIRT1-7), PARPS, and CD38, regulating DNA repair, mitochondrial biogenesis, circadian rhythm, inflammation, and cellular senescence. Supplementation elevates NAD* levels, restoring sirtuin activity, enhancing mitochondrial efficiency, and supporting energy metabolism. 
• MOTS-C acts as a retrograde mitochondrial signal. It activates AMPK, promotes PGC-1a expression, increases fatty acid oxidation, improves insulin sensitivity, enhances metabolic flexibility, and protects against age- and diet-induced metabolic dysfunction. 
• 5-Amino-1MQ is a selective inhibitor of nicotinamide N-methyltransferase (NNMT). By blocking NNMT, it reduces 1- methylnicotinamide production, preserves nicotinamide for NAD* synthesis, increases intracellular NAD*, shifts metabolism toward oxidative pathways, reduces fat storage, and enhances mitochondrial function and energy expenditure. 

The triple combination works synergistically to elevate NAD* pools, optimize mitochondrial performance, improve metabolic efficiency, reduce adipose accumulation, and support cellular resilience and longevity pathways. 

Indications & Usage 

Limitless is used to support cellular energy, metabolic health, and longevity processes. It is indicated for: 

• Enhancement of mitochondrial function and energy production 
• Promotion of fat oxidation and healthy body composition 
• Support for metabolic flexibility and insulin sensitivity 
• Assistance in cellular repair, resilience, and anti-aging metabolic pathways 

Contraindications & Warnings 

Do not use if you have: 

• Known hypersensitivity to NAD*, MOTS-C, 5-Amino-1MQ, or any excipient Active malignancy or history of cancer 
• Severe uncontrolled diabetes mellitus or insulin resistance syndromes 
• Severe hepatic or renal impairment 
• Pregnancy or breastfeeding 
• Age under 18 years 

Warnings 

• Use only under medical supervision with regular monitoring (glucose, lipids, liver function, and clinical parameters). 
• Not a substitute for diet, exercise, or approved medical therapies for metabolic disorders or obesity. Potential for glucose intolerance or transient changes in energy/blood pressure. 
• Discontinue immediately and seek medical attention if severe symptoms occur (e.g., rapid heartbeat, severe headache, chest pain, or signs of allergic reaction). 

Dosage & Administration 

• Subcutaneous injection only. 
• 5 Clicks (Light / Entry Protocol): 5 mg total actives (NAD* ~4.17 mg/MOTS-C≈0.42 mg/5-Amino-1MQ ≈0.42 mg) – yields 48 doses 
• 10 Clicks (Standard Performance / Longevity): 10 mg total actives (NAD*~8.33 mg/MOTS-C ~0.83 mg/5-Amino-1MQ ~0.83 mg) – yields 24 doses 
• 12 Clicks (Optimized Weekly Protocol): 12 mg total actives (NAD* ~10.0 mg/MOTS-C 1.0 mg/5-Amino-1MQ ≈1.0 mg) – yields 20 doses 
• 20 Clicks (Advanced Metabolic Protocol): 20 mg total actives (NAD* ~16.7 mg/MOTS-C≈1.67 mg/5-Amino-1MQ ~1.67 mg)-yields 12 doses 
• Frequency: Once daily (consistent timing recommended) 
• Timing: Morning (preferred for energy/metabolic support) or evening (for recovery/sleep quality) 

Administration Instructions

1. Wash hands and prepare a clean surface. 
2. Attach a sterile needle. 
3. Dial the required number of clicks. 
4. Clean injection site (abdomen or thigh) with alcohol swab. 
5. Insert needle at 45-90° angle and inject slowly. 
6. Withdraw needle, dispose safely, and cap the pen. 
7. Rotate injection sites to minimize irritation. 
8. Always inspect solution before use: Do not inject if cloudy, discoloured, or containing particles. 

Side Effects 

The Limitless combination is generally well tolerated. Reported reactions are uncommon and usually mild/transient, including: 

• Mild injection-site irritation, redness, or itching 
• Transient headache, light-headedness, or flushing 
• Temporary changes in energy levels, appetite, or sleep pattern during initial use 
• Rare mild gastrointestinal discomfort or nausea 
• Rare restlessness or mild palpitations (dose-related) 
• If any severe or persistent symptoms occur (e.g., rapid heartbeat, severe headache, breathing difficulty, or allergic signs), discontinue use and contact your healthcare provider immediately. 

Storage & Handling 

• Store either in refrigerator (fridge); never freeze or in a cool dry place (≤25-30°C / 77-86°F). Keep pen capped and protected from light and heat. 
• After first use: Same storage conditions. 
• Keep out of reach of children. 
• Discard if expired or solution appears abnormal. 

Powered by Precision MSSPT 

Peptide Pen formulations set the standard for research peptide delivery in challenging environments. Powered by exclusive MSSPT, each pen combines buffers, antioxidants, and proprietary agents in a compact, user-friendly injector, delivering strict control over pH, light, oxygen, oxidative factors, and moisture even under South Africa’s subtropical variability or the UAE’s extreme desert heat and humidity. This proprietary technology positions Peptide Pen as the premier choice for researchers in these regions: no mixing, no guesswork, and reliable, high-fidelity results despite demanding protocols and climates. Every Peptide Pen is built for exceptional durability, reliability, and performance- providing precision molecular stabilization in every dose, wherever your research takes you. 

IMPORTANT NOTICE 

This product is not intended to diagnose, treat, cure, or prevent any disease. Statements have not been evaluated by the FDA, SAHPRA, or other authorities. Always consult a licensed healthcare provider before use, especially if pregnant, breastfeeding, under 18, or managing medical conditions.

MSSPT PEPTIDE PEN LEAN DREAMS – R 1250

Lean Dreams combines two synthetic peptides with complementary actions on sleep architecture, metabolic regulation, and nocturnal recovery: 

• DSIP (Delta Sleep-Inducing Peptide): A nonapeptide with the sequence Trp–Ala-Gly-Gly-Asp–Ala–Ser-Gly-Glu (WAGGDASGE). 
• AOD-9604 (Anti–Obesity Drug-9604): A modified fragment of human growth hormone (hGH) comprising amino acids 177-191 with an N-terminal tyrosine. Sequence: H-Tyr-Leu-Arg-Ile-Val-Gln-Cys-Arg–Ser-Val-Glu-Gly-Ser-Cys-Gly-Phe- OH (disulfide bridge between Cys7 and Cys14). 

Mechanism of Action 

DSIP acts as a neuromodulator and sleep-regulatory peptide. It promotes delta-wave (slow–wave) sleep, normalizes sleep-wake cycles, reduces stress-induced arousal, and modulates GABAergic, serotonergic, and opioid neurotransmission. It exhibits mild anti-inflammatory, antioxidant, and stress-protective properties, helping to improve sleep depth and restorative quality. 

AOD-9604 retains the lipolytic and anti-lipogenic effects of hGH without stimulating IGF–1 or affecting glucose metabolism. It activates ẞ3-adrenergic receptors in adipose tissue, enhances lipolysis and fatty acid oxidation, inhibits adipocyte differentiation, and supports lean mass preservation during rest. 

The combination synergistically enhances deep restorative sleep, optimizes overnight fat metabolism, reduces catabolic stress, and supports tissue repair and metabolic health during nocturnal recovery phases. 

Indications & Usage 

Lean Dreams is used to support sleep quality, nocturnal metabolic health, and recovery. It is indicated for: 

• Promotion of deeper, more restorative sleep stages 
• Support for fat metabolism and body composition during rest 
• Assistance with difficulty maintaining sleep or recovery from physical/mental stress
• Improvement in overnight tissue repair, energy restoration, and daytime vitality 

Contraindications & Warnings 

Do not use if you have: 

• Known hypersensitivity to DSIP, AOD-9604, or any excipient 
• Active malignancy or history of hormone-dependent cancer 
• Severe uncontrolled psychiatric disorders (e.g., severe depression, psychosis) 
• Untreated sleep apnea or severe respiratory disorders 
• Age under 18 years 
• Pregnancy or breastfeeding

Warnings 

• Use only under medical supervision. 
• Not a substitute for standard medical treatment of insomnia, sleep-disordered breathing, obesity, or metabolic disorders. 
• Avoid operating machinery or driving until individual effects on alertness are known. 
• Discontinue immediately and seek medical attention if severe symptoms occur (e.g., chest pain, severe dizziness, breathing difficulties, or mood changes). 

Dosage & Administration 

• Subcutaneous injection only. 
• Standard Dose: 6 clicks (~250 mcg total actives: ~125 mcg DSIP + 125 mcg AOD-9604) 
• Timing: 30-60 minutes before bedtime 
• Frequency: Once per night 
• Usage Protocol: Best results occur with consistent nightly use over a 4-6 week cycle 

Administration Instructions

1. Wash hands and prepare a clean surface. 
2. Attach a sterile needle. 
3. Dial 6 clicks. 
4. Clean injection site (abdomen or thigh) with alcohol swab. 
5. Insert needle at 45-90° angle and inject slowly. 
6. Withdraw needle, dispose safely, and cap the pen. 
7. Rotate injection sites to minimize irritation. 
8. Always inspect solution before use: Do not inject if cloudy, discoloured, or containing particles. 

Side Effects 

Lean Dreams is generally well tolerated. Reported reactions are uncommon and usually mild/transient, including: 

• Mild injection-site irritation, redness, or itching 
• Transient headache or light-headedness 
• Temporary vivid dreams or changes in sleep pattern during initial days 
• Rare mild gastrointestinal discomfort or nausea 
• Rare restlessness or mild flushing (usually dose-related) 
• If any severe or persistent symptoms occur (e.g., rapid heartbeat, severe headache, breathing difficulty, or mood changes), discontinue use and contact your healthcare provider immediately. 

Storage & Handling 

• Store either in refrigerator (fridge); never freeze or in a cool dry place (≤25-30°C / 77-86°F).
• Keep pen capped and protected from light and heat. 
• After first use: Same storage conditions. 
• Keep out of reach of children. 
• Discard if expired or solution appears abnormal. 

Powered by Precision MSSPT 

Peptide Pen formulations set the standard for research peptide delivery in challenging environments. Powered by exclusive MSSPT, each pen combines buffers, antioxidants, and proprietary agents in a compact, user-friendly injector delivering strict control over pH, light, oxygen, oxidative factors, and moisture even under South Africa’s subtropical variability or the UAE’s extreme desert heat and humidity. This proprietary technology positions Peptide Pen as the premier choice for researchers in these regions: no mixing, no guesswork, and reliable, high-fidelity results despite demanding protocols and climates. Every Peptide Pen is built for exceptional durability, reliability, and performance, providing precision molecular stabilization in every dose, wherever your research takes you. 

IMPORTANT NOTICE 

This product is not intended to diagnose, treat, cure, or prevent any disease. Statements have not been evaluated by the FDA, SAHPRA, or other authorities. Always consult a licensed healthcare provider before use, especially if pregnant, breastfeeding, under 18, or managing medical conditions.

MSSPT PEPTIDE PEN LADY GH – R 1500

Lady GH contains recombinant human growth hormone (rhGH), also known as somatropin. It is a single-chain polypeptide of 191 amino acids with a molecular weight of approximately 22,124 Da. The sequence is identical to endogenous pituitary-derived human growth hormone. Somatropin is produced using recombinant DNA technology in a mammalian cell expression system, ensuring full biological equivalence to the native hormone. 

Mechanism of Action 

Somatropin binds to the growth hormone receptor (GHR) on target cells, inducing receptor dimerization and activation of the JAK2/STAT5 signalling pathway. Key downstream effects include: 

• Stimulation of insulin-like growth factor–1 (IGF–1) production in liver and local tissues 
• Promotion of lipolysis in adipose tissue and inhibition of lipogenesis 
• Increased protein synthesis and amino acid uptake in muscle 
• Enhancement of collagen synthesis and extracellular matrix remodelling 
• Stimulation of chondrocyte proliferation in growth plates (prior to epiphyseal closure) 
• Modulation of carbohydrate metabolism (reduced insulin sensitivity, increased hepatic glucose output) 
• Support for bone mineral density, connective tissue integrity, and tissue repair 
• These actions collectively support anabolic processes, fat metabolism, tissue regeneration, and metabolic homeostasis. 

Indications & Usage 

Lady GH is used to support physiological processes associated with growth hormone activity in adults. It is indicated for: 

• Promotion of lean body mass and reduction of adipose tissue 
• Support for muscle strength, recovery, and tissue repair 
• Assistance in maintaining bone density and connective tissue health 
• Improvement in energy, vitality, and overall physical resilience during age-related decline or recovery phases 

 Contraindications & Warnings 

Do not use if you have: 

• Known hypersensitivity to somatropin or any excipient 
• Active malignancy or history of cancer (active neoplastic disease) 
• Evidence of intracranial lesion or increased intracranial pressure 
• Severe obesity or untreated obstructive sleep apnea 
• Diabetic retinopathy (proliferative or pre-proliferative) 
• Acute critical illness (e.g., post-major surgery, multiple trauma, acute respiratory failure) 
• Age under 18 years (unless under specialist endocrinology care) 
• Pregnancy or breastfeeding 

Warnings

• Use only under medical supervision with regular monitoring (IGF-1 levels, glucose, thyroid function, and clinical parameters). 
• Not a substitute for lifestyle interventions, approved therapies for metabolic disorders, or treatment of underlying conditions. 
• Increased risk of glucose intolerance, diabetes, or worsening of pre-existing diabetes. 
• Potential for fluid retention, arthralgia, myalgia, or carpal tunnel syndrome (usually transient). Discontinue immediately and seek medical attention if signs of intracranial hypertension (severe headache, visual changes), pancreatitis, or severe allergic reaction occur. 

Dosage & Administration 

• Subcutaneous injection only. 
• Standard Dose: 1 IU per day (1 dose = 1 IU) 
  • 1 IU ≈ 8 clicks
• Quick reference:
  • 2 IU = 16 clicks
  • 3 IU = 24 clicks
  • 4 IU = 32 clicks
  • 5 IU = 40 clicks
• Frequency: Daily dosing, with 2-3 days off per week recommended for optimal long-term benefit 
• Timing: Best taken in the morning on an empty stomach or as directed by your healthcare provider Cycle: 4-6 weeks on, followed by a break as advised 
• Pen Duration on Standard Protocol: Up to 40 doses per pen (full pen lasts ≈40 days with daily use)

Administration Instructions:

1. Wash hands and prepare a clean surface. 
2. Attach a sterile needle. 
3. Dial the required number of clicks. 
4. Clean injection site (abdomen or upper thigh) with alcohol swab. 
5. Insert needle at 45-90° angle and inject slowly. 
6. Withdraw needle, dispose safely, and cap the pen. 
7. Rotate injection sites to minimize irritation. 
8. Always inspect solution before use: Do not inject if cloudy, discoloured, or containing particles. 

Side Effects 

Somatropin is generally well tolerated at physiological replacement doses. Common or potential adverse reactions include: 

• Injection-site reactions (pain, redness, swelling, lipoatrophy) 
• Fluid retention/edema (hands, feet, face) 
• Arthralgia, myalgia, or carpal tunnel syndrome (usually transient) 
• Headache or light-headedness 
• Glucose intolerance or hyperglycaemia 
• Rare: Intracranial hypertension (pseudotumor cerebri), pancreatitis, hypothyroidism, gynecomastia (in males) 
• If any severe or persistent symptoms occur (e.g., severe headache with visual changes, severe abdominal pain, or signs of allergic reaction), discontinue use and contact your healthcare provider immediately. 

Storage & Handling 

• Store either in refrigerator (fridge); never freeze or in a cool dry place (≤25-30°C / 77-86°F). Keep pen capped and protected from light and heat. 
• After first use: Same storage conditions. 
• Keep out of reach of children. 
• Discard if expired or solution appears abnormal. 

Powered by Precision MSSPT 

Peptide Pen formulations set the standard for research peptide delivery in challenging environments. Powered by exclusive MSSPT, each pen combines buffers, antioxidants, and proprietary agents in a compact, user-friendly injector, delivering strict control over pH, light, oxygen, oxidative factors, and moisture even under South Africa’s subtropical variability or the UAE’s extreme desert heat and humidity. This proprietary technology positions Peptide Pen as the premier choice for researchers in these regions: no mixing, no guesswork, and reliable, high-fidelity results despite demanding protocols and climates. Every Peptide Pen is built for exceptional durability, reliability, and performance- providing precision molecular stabilization in every dose, wherever your research takes you. 

IMPORTANT NOTICE 

This product is not intended to diagnose, treat, cure, or prevent any disease. Statements have not been evaluated by the FDA, SAHPRA, or other authorities. Always consult a licensed healthcare provider before use, especially if pregnant, breastfeeding, under 18, or managing medical conditions.

MSSPT PEPTIDE PEN IMMUNE BOOST – R 1200

Thymosin Alpha–1 (Ta1) is a synthetic 28-amino-acid peptide identical to the naturally occurring N-terminal fragment of prothymosin alpha, a protein produced primarily in the thymus gland. Chemical Structure: Ac-Ser–Asp-Ala-Ala-Val-Asp-Thr–Ser–Ser–Glu–Ile-Thr-Thr–Lys–Asp–Leu–Lys-Glu-Lys–Lys-Glu-Val–Val-Glu-Glu-Ala-Glu- Asn-OH 

(Acetylated at N-terminus; free carboxylic acid at C–terminus) 

Mechanism of Action 

Thymosin Alpha–1 acts as a master regulator of immune homeostasis. It binds to toll–like receptors (TLR2/TLR9) on immune cells and activates multiple intracellular signalling pathways (NF-κB, MAPK, STAT, PI3K/Akt). Key effects include: 

• Enhancement of T-cell maturation, differentiation, and activation 
• Stimulation of natural killer (NK) cell cytotoxicity and cytokine production 
• Promotion of dendritic cell maturation and antigen presentation 
• Upregulation of IL-2, IL-10, IFN-y, and IL-12 production 
• Restoration of Th1/Th2 balance and reversal of immunosuppression 
• Direct antiviral, antibacterial, and antifungal activity 
• Increased expression of MHC class I molecules and antioxidant enzymes 

These actions result in broad-spectrum immune potentiation, improved host defence, and accelerated recovery from immune suppression or dysregulation. 

Indications & Usage 

Immune Boost (Thymosin Alpha-1) is used to support and restore immune function. It is indicated for: 

• • Enhancement of immune competence during periods of increased demand (stress, recovery, environmental exposure) 
  • Assistance in age-related or acquired decline in T-cell and NK-cell function 
  • Support for recovery from acute or chronic immune challenges 
  • General immune modulation and resilience at the cellular level 

    Contraindications & Warnings 

    Do not use if you have: 

    • Known hypersensitivity to Thymosin Alpha-1 or any excipient 
    • Active autoimmune disease in acute flare (e.g., uncontrolled rheumatoid arthritis, lupus) 
    • Organ or hematopoietic stem cell transplant recipients on high-dose immunosuppression Active untreated malignancy (unless under oncologist supervision) 
    • Age under 18 years 
    • Pregnancy or breastfeeding

      Warnings 

      • Use only under medical supervision. 
      • Not a substitute for vaccination, antimicrobial therapy, or standard treatment of infections/immunodeficiency. 
      • Monitor for signs of immune overstimulation (fever, rash, arthralgia) during initial use.
      • Discontinue immediately and seek medical attention if severe allergic reactions, organ inflammation, or unexpected symptoms occur. 

        Dosage & Administration 

        • Subcutaneous injection only. 
        • Beginner/Mild Support (0.125 mg): 6 clicks daily- 5 days on / 2 days off (yields ~20 doses) 
        • Moderate Support (0.25 mg): 12 clicks daily- 5 days on /2 days off (yields ~10 doses) 
        • Advanced/Clinical Support (0.5 mg): 24 clicks daily- 5 days on / 2 days off (yields ≈5 doses) Frequency: 5 days on / 2 days off (e.g., Monday-Friday on, Saturday-Sunday off) 

          Administration Instructions

          1. Wash hands and prepare a clean surface. 
          2. Attach a sterile needle. 
          3. Dial the required number of clicks. 
          4. Clean injection site (abdomen or upper thigh) with alcohol swab. 
          5. Insert needle at 45-90° angle and inject slowly. 
          6. Withdraw needle, dispose safely, and cap the pen. 
          7. Rotate injection sites to minimize irritation. 
          8. Always inspect solution before use: Do not inject if cloudy, discoloured, or containing particles. 

             Side Effects 

             Thymosin Alpha-1 is generally very well tolerated with a long safety record. Reported reactions are rare and mild, including: 

             • Transient injection-site redness, itching, or mild swelling 
             • Mild flu-like symptoms (low-grade fever, fatigue, myalgia) during initial doses 
             • Headache or light-headedness 
             • Rare transient changes in appetite or sleep pattern 
             • If any severe or persistent symptoms occur (e.g., high fever, rash, joint swelling, or allergic signs), discontinue use and contact your healthcare provider immediately. 
        • Timing: Every morning 

          Storage & Handling 

          • Store either in refrigerator (fridge); never freeze or in a cool dry place (≤25-30°C / 77-86°F). 
          • Keep pen capped and protected from light and heat. 
          • After first use: Same storage conditions. 
          • Keep out of reach of children. 
          • Discard if expired or solution appears abnormal. 

            Powered by Precision MSSPT 

            Peptide Pen formulations set the standard for research peptide delivery in challenging environments. Powered by exclusive MSSPT, each pen combines buffers, antioxidants, and proprietary agents in a compact, user-friendly injector delivering strict control over pH, light, oxygen, oxidative factors, and moisture even under South Africa’s subtropical variability or the UAE’s extreme desert heat and humidity. This proprietary technology positions Peptide Pen as the premier choice for researchers in these regions: no mixing, no guesswork, and reliable, high-fidelity results despite demanding protocols and climates. Every Peptide Pen is built for exceptional durability, reliability, and performance, providing precision molecular stabilization in every dose, wherever your research takes you. 

            • IMPORTANT NOTICE 

              This product is not intended to diagnose, treat, cure, or prevent any disease. Statements have not been evaluated by the FDA, SAHPRA, or other authorities. Always consult a licensed healthcare provider before use, especially if pregnant, breastfeeding, under 18, or managing medical conditions.

MSSPT PEPTIDE PEN GLUTATHIONE – R 125

Glutathione is a naturally occurring tripeptide composed of three amino acids: L–glutamic acid, L–cysteine, and glycine. Its chemical structure is y-L-Glutamyl-L-cysteinyl-glycine (y-Glu-Cys-Gly), with a uniquey-glutamyl linkage between glutamate and cysteine that confers resistance to standard peptidase degradation. Glutathione exists in reduced (GSH) and oxidized (GSSG) forms, with GSH being the predominant and biologically active state in cells.

Mechanism of Action

Glutathione is the body’s primary intracellular antioxidant and phase II detoxification cofactor. Its principal actions include:

Direct scavenging of reactive oxygen species (ROS), free radicals, and peroxides Regeneration of other antioxidants (vitamin C, vitamin E, coenzyme Q10)

Conjugation with xenobiotics, heavy metals, and electrophilic metabolites via glutathione S-transferases (GSTs) for excretion

Maintenance of cellular redox homeostasis through the glutathione peroxidase/reductase cycle

Modulation of inflammatory signalling (e.g., NF-kB inhibition)

Support for mitochondrial function and protection against oxidative damage to lipids, proteins, and DNA

By replenishing intracellular GSH pools, exogenous administration supports systemic antioxidant capacity, detoxification pathways, and cellular resilience against oxidative and toxic stress.

Indications & Usage

Glutathione is used to support antioxidant defence, detoxification, and cellular health. It is indicated for:

Enhancement of systemic antioxidant capacity and reduction of oxidative stress

Support for detoxification pathways (liver, kidneys, and other tissues)

Assistance during periods of increased oxidative load (e.g., intense physical activity, environmental exposure, recovery phases)

Maintenance of skin health, energy metabolism, and general cellular protection

Contraindications & Warnings

Do not use if you have:

Known hypersensitivity to glutathione or any excipient

Active asthma or history of severe bronchospasm (rare reports of respiratory reactions with intravenous glutathione)

Severe renal impairment (especially with high-dose use)

Pregnancy or breastfeeding (insufficient safety data)

Age under 18 years

Warnings

Use only under medical supervision.

Not a substitute for standard medical treatment of liver disease, chronic illness, or toxicity. High doses may transiently increase transaminases or cause mild gastrointestinal upset.

Discontinue immediately and seek medical attention if severe symptoms occur (e.g., difficulty breathing, severe rash, or anaphylactoid reaction).

Dosage & Administration

Subcutaneous injection only.

Low Dose (50 mg): 12 clicks daily- beginner or maintenance antioxidant support (yields 20 doses) Moderate Dose (100 mg): 24 clicks daily- enhanced skin clarity and moderate detoxification support (yields 10 doses)

High Dose (200 mg): 48 clicks daily- intensive oxidative stress reduction, skin pigmentation concerns, or therapeutic detox protocols (yields 5 doses)

Frequency: Once daily

Timing: Morning or evening – consistent timing preferred

Administration Instructions

Wash hands and prepare a clean surface.

Attach a sterile needle.

Dial the required number of clicks.

Clean injection site (abdomen or thigh) with alcohol swab.

Insert needle at 45-90° angle and inject slowly.

Withdraw needle, dispose safely, and cap the pen.

Rotate injection sites to minimize irritation.

Always inspect solution before use: Do not inject if cloudy, discoloured, or containing particles.

Side Effects

Glutathione is generally very well tolerated. Reported reactions are uncommon and usually mild/transient, including:

Mild injection-site irritation, redness, or itching

Transient headache or light-headedness

Temporary nausea or gastrointestinal discomfort

Rare metallic taste or flushing (dose-related)

Very rare hypersensitivity reactions (rash, urticaria, bronchospasm)

If any severe or persistent symptoms occur (e.g., difficulty breathing, severe rash, or anaphylactoid reaction), discontinue use and seek immediate medical attention.

Storage & Handling

Store either in refrigerator (fridge); never freeze or in a cool dry place (≤25-30°C / 77-86°F).

Keep pen capped and protected from light and heat.

After first use: Same storage conditions.

Keep out of reach of children.

Discard if expired or solution appears abnormal.

Powered by Precision MSSPT

Peptide Pen formulations set the standard for research peptide delivery in challenging environments. Powered by exclusive MSSPT, each pen combines buffers, antioxidants, and proprietary agents in a compact, user-friendly injector delivering strict control over pH, light, oxygen, oxidative factors, and moisture even under South Africa’s subtropical variability or the UAE’s extreme desert heat and humidity. This proprietary technology positions Peptide Pen as the premier choice for researchers in these regions: no mixing, no guesswork, and reliable, high-fidelity results despite demanding protocols and climates. Every Peptide Pen is built for exceptional durability, reliability, and performance–providing precision molecular stabilization in every dose, wherever your research takes you.

IMPORTANT NOTICE

This product is not intended to diagnose, treat, cure, or prevent any disease. Statements have not been evaluated by the FDA, SAHPRA, or other authorities. Always consult a licensed healthcare provider before use, especially if pregnant, breastfeeding, under 18, or managing medical conditions.

MSSPT PEPTIDE PEN GLOW STACK – R 3000

Glow Stack is a combination of three well–characterized synthetic peptides:

GHK–Cu (Glycyl-L-Histidyl-L-Lysine Copper): A naturally occurring tripeptide-copper complex found in human plasma, saliva, and urine. Chemical structure: Gly-His-Lys-Cu2+.

BPC-157 (Body Protection Compound-157): A synthetic pentadecapeptide derived from a protective protein in human gastric juice. Sequence: Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val.

TB-500 (Thymosin Beta-4 fragment): A synthetic version of the active domain of Thymosin Beta–4, a 43-amino-acid actin-sequestering protein. Key active fragment: Ac-LKKTETQ.

These peptides are combined to provide complementary regenerative, anti-inflammatory, and tissue-remodeling effects.

Mechanism of Action

GHK-Cu: Binds copper ions and modulates gene expression (upregulates >4,000 genes, downregulates >4,000). Stimulates collagen/elastin synthesis, glycosaminoglycan production, angiogenesis, extracellular matrix remodelling, antioxidant enzyme activity (SOD, catalase), and anti-inflammatory pathways (suppresses NF-κB, TNF-α, IL-6). Promotes wound healing, skin/tissue repair, and anti-aging effects.

BPC-157: Accelerates angiogenesis (via VEGF and nitric oxide pathways), enhances fibroblast migration/proliferation, upregulates growth factors (FGF, EGF), protects endothelial integrity, modulates serotonin/dopamine systems, and exerts potent cytoprotective and anti-inflammatory effects across multiple tissues (muscle, tendon, ligament, GI tract, CNS).

TB-500: Promotes actin sequestration and polymerization, enhances cell migration, angiogenesis, and wound healing. Reduces inflammation, inhibits apoptosis, and supports tissue repair in muscle, tendon, ligament, and skin. The combination synergistically supports tissue regeneration, reduces inflammation, improves extracellular matrix quality, and accelerates recovery across skin, musculoskeletal, and soft-tissue systems.

Indications & Usage

Glow Stack is used to support tissue repair, skin health, and regenerative processes. It is indicated for:

Promotion of skin rejuvenation, elasticity, and collagen production

Acceleration of healing in muscles, tendons, ligaments, and joints

Reduction of inflammation and support for recovery from physical stress or injury Maintenance of connective tissue integrity and anti-aging effects at the cellular level

Contraindications & Warnings

Do not use if you have:

Known hypersensitivity to GHK-Cu, BPC-157, TB-500, copper, or any excipient Active malignancy or history of cancer (due to pro-angiogenic properties)

Severe uncontrolled bleeding disorders or acute thrombosis

Pregnancy or breastfeeding

Age under 18 years

Warnings

Use only under medical supervision.

Not a substitute for standard medical or surgical treatment of injuries, wounds, or inflammatory conditions.

Discontinue immediately and seek medical attention if unusual symptoms occur (e.g., severe swelling, fever, or signs of infection/allergic reaction).

Avoid concurrent use with other strong pro-angiogenic agents unless under specialist guidance.

Dosage & Administration

Subcutaneous injection only.

5-Click Dose (Light/Maintenance): 1.46 mg total actives (1.04 mg GHK-Cu + 0.21 mg BPC-157 +0.21 mg TB-500) – yields 48 doses

10–Click Dose (Standard Glow Protocol): 2.92 mg total actives (2.08 mg GHK-Cu + 0.42 mg BPC-157 + 0.42 mg TB-500) – yields 24 doses

12-Click Dose (Enhanced Repair / Aesthetic Protocol): 3.50 mg total actives (2.50 mg

GHK-Cu + 0.50 mg BPC-157 +0.50 mg TB-500) – yields 20 doses

Frequency: Once daily

Timing: Morning or evening- consistent timing preferred

Administration Instructions

Wash hands and prepare a clean surface.

Attach a sterile needle.

Dial the required number of clicks.

Clean injection site (abdomen or thigh) with alcohol swab.

Insert needle at 45-90° angle and inject slowly.

Withdraw needle, dispose safely, and cap the pen.

Rotate injection sites to minimize irritation.

Always inspect solution before use: Do not inject if cloudy, discoloured, or containing particles. The Glow Stack Pen solution has a deep blue coloration, which is normal.

Side Effects

The Glow Stack combination is generally well tolerated. Reported reactions are uncommon and usually mild/transient, including:

Mild injection-site irritation, redness, or itching

Transient headache or light–headedness

Temporary changes in energy levels or sleep patterns during initial days

Rare mild gastrointestinal discomfort or flushing

Rare copper-related effects (metallic taste, nausea) with high cumulative GHK–Cu exposure

If any severe or persistent symptoms occur (e.g., severe rash, swelling, or allergic signs), discontinue use and contact your healthcare provider immediately.

Storage & Handling

Store either in refrigerator (fridge); never freeze or in a cool dry place (≤25-30°C / 77-86°F).

Keep pen capped and protected from light and heat.

After first use: Same storage conditions.

Keep out of reach of children.

Discard if expired or solution appears abnormal.

Powered by Precision MSSPT

Peptide Pen formulations set the standard for research peptide delivery in challenging environments. Powered by exclusive MSSPT, each pen combines buffers, antioxidants, and proprietary agents in a compact, user-friendly injector delivering strict control over pH, light, oxygen, oxidative factors, and moisture even under South Africa’s subtropical variability or the UAE’s extreme desert heat and humidity. This proprietary technology positions Peptide Pen as the premier choice for researchers in these regions: no mixing, no guesswork, and reliable, high-fidelity results despite demanding protocols and climates. Every Peptide Pen is built for exceptional durability, reliability, and performance-providing precision molecular stabilization in every dose, wherever your research takes you.

IMPORTANT NOTICE

This product is not intended to diagnose, treat, cure, or prevent any disease. Statements have not been evaluated by the FDA, SAHPRA, or other authorities. Always consult a licensed healthcare provider before use, especially if pregnant, breastfeeding, under 18, or managing medical conditions.

MSSPT PEPTIDE PEN FOREVER YOUN.               R 2450

Epitalon (also known as Epithalon) is a synthetic tetrapeptide with the amino acid sequence Ala-Glu-Asp–Gly (AEDG). It is a mimetic of epithalamin, a natural peptide complex derived from the pineal gland and belongs to the class of Khavinson bioregulator peptides.

Mechanism of Action

Epitalon primarily activates telomerase (via upregulation of telomerase reverse transcriptase gene expression), promoting telomere elongation and delaying replicative senescence in somatic cells. Additional mechanisms include:

Normalization of pineal melatonin secretion and circadian rhythm regulation.

Modulation of neuroendocrine-immune interactions

Enhancement of antioxidant enzyme activity and reduction of oxidative stress

Regulation of gene expression related to aging, DNA repair, and cellular longevity

These effects contribute to cellular rejuvenation, improved endocrine balance, and support for healthy aging processes.

Indications & Usage

Forever Young (Epitalon) is used to support anti-aging, longevity, and cellular health. It is indicated for:

Promotion of telomere maintenance and cellular longevity

Enhancement of sleep quality and circadian rhythm regulation

Support for hormonal balance, immune resilience, and neuroprotection

Assistance in mitigating age-related decline in vitality and recovery

Contraindications & Warnings

Do not use if you have:

Known hypersensitivity to Epitalon or any excipient

Active malignancy or history of cancer (theoretical concern regarding cell proliferation) Severe uncontrolled endocrine disorders

Age under 18 years

Pregnancy or breastfeeding

Warnings

Use only under medical supervision.

Not a substitute for standard medical care, lifestyle interventions, or approved therapies for age- related conditions.

Periodic monitoring (e.g., hormonal levels, sleep quality) is advised during long-term use.

Discontinue immediately and seek medical attention if unusual symptoms occur (e.g., severe hormonal changes, sleep disturbances, or signs of allergic reaction).

Dosage & Administration

Subcutaneous injection only.

Recommended Dose: 12 clicks nightly before bed (delivers a full anti-aging dose) Frequency: Nightly administration

Timing: Evening/before bed to align with circadian rhythms

Cycle Protocol: 20 consecutive days on, followed by a 3-month break before repeating the cycle Pen

Duration: Delivers a full 20-day anti-aging cycle per pen

Administration Instructions

Prime pen before first use: Dial to 12 clicks and press until a drop appears at the tip (repeat if needed).

Select dose: Dial to 12 clicks.

Apply to clean skin (commonly abdomen or thigh).

Press and hold for 6 seconds to deliver the dose. 5.Replace cap after use.

Always inspect solution: Do not use if cloudy, discoloured, or containing particles.

Side Effects

Epitalon is generally well tolerated in research settings. Reported reactions are rare and mild/transient, including:

Mild injection–site irritation or redness

Transient headache or light-headedness

Temporary changes in sleep patterns or energy levels during initial cycles

Rare mild gastrointestinal discomfort

If any severe or persistent symptoms occur (e.g., severe headache, hormonal changes, or allergic

signs), discontinue use and contact your healthcare provider immediately.

Storage & Handling

Store in a cool, dry place away from light; replace cap after use.

Ensure solution is clear and properly stored.

Discontinue use if solution appears cloudy or discolored.

Keep out of reach of children.

Discard if expired or solution appears abnormal.

Powered by Precision MSSPT

Peptide Pen formulations set the standard for research peptide delivery in challenging environments. Powered by exclusive MSSPT, each pen combines buffers, antioxidants, and proprietary agents in a compact, user-friendly injector delivering strict control over pH, light, oxygen, oxidative factors, and moisture even under South Africa’s subtropical variability or the UAE’s extreme desert heat and humidity. This proprietary technology positions Peptide Pen as the premier choice for researchers in these regions: no mixing, no guesswork, and reliable, high-fidelity results despite demanding protocols and climates. Every Peptide Pen is built for exceptional durability, reliability, and performance-providing precision molecular stabilization in every dose, wherever your research takes you.

IMPORTANT NOTICE

This product is not intended to diagnose, treat, cure, or prevent any disease. Statements have not been evaluated by the FDA, SAHPRA, or other authorities. Always consult a licensed healthcare provider before use, especially if pregnant, breastfeeding, under 18, or managing medical conditions. All products are intended for laboratory and research purposes only; not approved for human consumption, medical, or therapeutic application.

MSSPT PEPTIDE PEN FAT AWAY – R 1200

AOD-9604 (Anti–Obesity Drug-9604) is a synthetic peptide fragment derived from the C-terminal region of human growth hormone (hGH), specifically amino acids 177-191 with an additional tyrosine residue at the N-terminus.

Chemical Structure H-Tyr-Leu-Arg-Ile-Val-Gln-Cys-Arg–Ser-Val-Glu-Gly-Ser-Cys-Gly-Phe-OH

(15 amino acids; disulfide bridge between Cys7 and Cys14)

Mechanism of Action

AOD-9604 retains the lipolytic (fat-burning) and anti-lipogenic properties of native hGH without stimulating insulin-like growth factor-1 (IGF-1) production or affecting glucose metabolism. It acts primarily through:

Stimulation of ẞ3–adrenergic receptors in adipose tissue increased lipolysis and fatty acid oxidation

Inhibition of lipogenesis in adipocytes

Enhancement of mitochondrial fat oxidation

Preservation of lean body mass during caloric restriction

Mild anti-inflammatory effects in adipose tissue

These actions promote targeted fat metabolism while supporting metabolic health and body composition without the broader endocrine effects of full-length hGH.

Indications & Usage

Fat Away is used to support healthy fat metabolism and body composition. It is indicated for:

Promotion of fat oxidation and reduction of adipose tissue accumulation

Preservation of lean muscle mass during weight management or caloric deficit

Support for metabolic efficiency and energy utilization

Assistance in achieving physique and wellness goals when combined with diet and exercise

Contraindications & Warnings

Do not use if you have:

Known hypersensitivity to AOD-9604 or any excipient

Active malignancy or history of hormone–dependent cancer

Severe uncontrolled diabetes mellitus or insulin resistance syndromes

Severe hepatic or renal impairment

Age under 18 years

Pregnancy or breastfeeding

Warnings

Use only under medical supervision.

Not a substitute for diet, exercise, or approved medical therapies for obesity or metabolic disorders. Monitor blood glucose and metabolic parameters if clinically indicated.

Discontinue immediately and seek medical attention if severe symptoms occur (e.g., rapid heartbeat, severe headache, chest pain, or signs of allergic reaction).

Dosage & Administration

Subcutaneous injection only.

Standard Dose: 250-500 mcg per injection (0.25-0.5 mg)

250 mcg≈ 6 clicks

500 mcg 12 clicks

Frequency: Once daily (or 5-6 days/week with 1-2 days off for maintenance protocols)

Timing: Morning, on an empty stomach (wait 30-60 minutes before eating) to optimize metabolic effects

Cycle: 8-12 weeks on (extend to 12-16 weeks for sustained protocols), followed by 4-6 weeks off

Administration Instructions

Wash hands and prepare a clean surface.

Attach a sterile needle.

Dial the required number of clicks.

Clean injection site (abdomen or thigh) with alcohol swab.

Insert needle at 45-90° angle and inject slowly.

Withdraw needle, dispose safely, and cap the pen.

Rotate injection sites to minimize irritation.

Always inspect solution before use: Do not inject if cloudy, discoloured, or containing particles.

Side Effects

AOD-9604 is generally well tolerated. Reported reactions are uncommon and usually mild/transient, including:

Mild injection-site irritation, redness, or itching

Transient headache or light-headedness

Temporary changes in appetite or energy levels

Rare mild gastrointestinal discomfort

If any severe or persistent symptoms occur (e.g., rapid heartbeat, severe headache, or signs of allergic reaction), discontinue use and contact your healthcare provider immediately.

Storage & Handling

Store either in refrigerator (fridge); never freeze or in a cool dry place (≤25-30°C / 77-86°F).

Keep pen capped and protected from light and heat.

After first use: Same storage conditions.

Keep out of reach of children.

Discard if expired or solution appears abnormal.

Powered by Precision MSSPT

Peptide Pen formulations set the standard for research peptide delivery in challenging environments. Powered by exclusive MSSPT, each pen combines buffers, antioxidants, and proprietary agents in a compact, user-friendly injector delivering strict control over pH, light, oxygen, oxidative factors, and moisture even under South Africa’s subtropical variability or the UAE’s extreme desert heat and humidity. This proprietary technology positions Peptide Pen as the premier choice for researchers in these regions: no mixing, no guesswork, and reliable, high-fidelity results despite demanding protocols and climates. Every Peptide Pen is built for exceptional durability, reliability, and performance-providing precision molecular stabilization in every dose, wherever your research takes you.

IMPORTANT NOTICE

This product is not intended to diagnose, treat, cure, or prevent any disease. Statements have not been evaluated by the FDA, SAHPRA, or other authorities. Always consult a licensed healthcare provider before use, especially if pregnant, breastfeeding, under 18, or managing medical conditions.

MSSPT PEPTIDE PEN EASY SLEEP – R 900

Easy Sleep combines two synthetic peptides:

AOD-9604 (Anti-Obesity Drug-9604): A modified fragment of human growth hormone (hGH) comprising amino acids 177-191 with an additional tyrosine residue at the N-terminus. Chemical structure: H-Tyr–Leu-Arg-Ile-Val-Gln-Cys-Arg- Ser-Val-Glu-Gly-Ser-Cys-Gly-Phe-OH (disulfide bridge between Cys7 and Cys14).

DSIP (Delta Sleep-Inducing Peptide): A nonapeptide with the sequence Trp-Ala-Gly-Gly-Asp-Ala-Ser-Gly-Glu. Together, these peptides act synergistically to support sleep architecture, recovery, and metabolic regulation during rest.

Mechanism of Action

AOD-9604 mimics selected lipolytic and anabolic effects of hGH without stimulating IGF-1 production or affecting glucose metabolism. It promotes lipolysis in adipose tissue, enhances fat oxidation, preserves lean mass, and supports tissue repair through modulation of local growth factor pathways and anti-inflammatory signalling. DSIP acts as a neuromodulator and sleep-regulatory peptide. It influences delta–wave (slow-wave) sleep generation, normalizes sleep-wake cycles, reduces stress-induced arousal, modulates GABAergic and serotonergic neurotransmission, and exhibits mild anti-inflammatory and antioxidant properties.

The combination supports deeper restorative sleep, improved nocturnal recovery, reduced nighttime metabolic disturbances, and enhanced overall sleep quality and daytime vitality.

Indications & Usage

Easy Sleep is used to support natural sleep quality and nighttime physiological recovery. It is indicated for:

Promotion of deeper, more restorative sleep stages

Assistance with difficulty falling asleep or maintaining sleep Support for recovery from physical or mental stress during rest

Maintenance of metabolic balance and tissue repair during sleep

General improvement in sleep architecture and daytime energy/resilience

Contraindications & Warnings

Do not use if you have:

Known hypersensitivity to AOD-9604, DSIP, or any excipient

Active malignancy or history of hormone–dependent cancer

Severe uncontrolled psychiatric disorders (e.g., severe depression, psychosis)

Untreated sleep apnea or severe respiratory disorders

Age under 18 years

Warnings

Pregnancy or breastfeeding

Use only under medical supervision.

Not a substitute for standard medical treatment of insomnia, sleep apnea, depression, or metabolic disorders.

Avoid operating machinery or driving until effects on alertness are known.

Discontinue immediately and seek medical attention if severe symptoms occur (e.g., chest pain, severe dizziness, breathing difficulties, or mood changes).

Dosage & Administration

Subcutaneous injection only.

Standard Dose: 6 clicks (~250 mcg total actives: ~125 mcg AOD–9604 + 125 mcg DSIP)

Timing: 30-60 minutes before bedtime

Frequency: Once per night

Usage Protocol: Best results occur with consistent nightly use over a 4-6 week cycle

Administration Instructions

Wash hands and prepare a clean surface.

Attach a sterile needle.

Dial 6 clicks.

Clean injection site (abdomen or thigh) with alcohol swab.

Insert needle at 45-90° angle and inject slowly.

Withdraw needle, dispose safely, and cap the pen.

Rotate injection sites to minimize irritation.

Always inspect solution before use: Do not inject if cloudy, discoloured, or containing particles.

Side Effects

Easy Sleep is generally well tolerated. Reported reactions are uncommon and usually mild/transient, including:

Mild injection-site irritation, redness, or itching

Transient headache or light–headedness

Temporary vivid dreams or changes in sleep pattern during initial days

Rare mild gastrointestinal discomfort or nausea

Rare restlessness or mild flushing (usually dose-related)

If any severe or persistent symptoms occur (e.g., rapid heartbeat, severe headache, breathing difficulty, or mood changes), discontinue use and contact your healthcare provider immediately.

Storage & Handling

Store either in refrigerator (fridge); never freeze or in a cool dry place (≤25-30°C / 77-86°F). Keep pen capped and protected from light and heat.

After first use: Same storage conditions.

Keep out of reach of children.

Discard if expired or solution appears abnormal.

Powered by Precision MSSPT

Peptide Pen formulations set the standard for research peptide delivery in challenging environments. Powered by exclusive MSSPT, each pen combines buffers, antioxidants, and proprietary agents in a compact, user–friendly injector delivering strict control over pH, light, oxygen, oxidative factors, and moisture even under South Africa’s subtropical variability or the UAE’s extreme desert heat and humidity. This proprietary technology positions Peptide Pen as the premier choice for researchers in these regions: no mixing, no guesswork, and reliable, high-fidelity results despite demanding protocols and climates. Every Peptide Pen is built for exceptional durability, reliability, and performance-providing precision molecular stabilization in every dose, wherever your research takes you.

IMPORTANT NOTICE

This product is not intended to diagnose, treat, cure, or prevent any disease. Statements have not been evaluated by the FDA, SAHPRA, or other authorities. Always consult a licensed healthcare provider before use, especially if pregnant, breastfeeding, under 18, or managing medical conditions.